Video wird geladen...

Video konnte nicht geladen werden

Beim Laden dieses Videos ist ein Problem aufgetreten. Dies könnte an einem vorübergehenden Netzwerkproblem liegen oder das Video ist möglicherweise nicht verfügbar.

One cell. Two new beginnings. Before a cell divides, it first copies its DNA. Then, during mitosis, the chromosomes condense, align at the cell's center, separate toward opposite sides, and form two new nuclei. Finally, cytokinesis divides the cytoplasm, producing two genetically identical daughter cells. This microscopic process allows... show more

Kekius Maximus

128,550 subscribers

21,514 Aufrufe • vor 22 Tagen •via X (Twitter)

Wissenschaft & Technologie

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

Mitosis is a part of the cell cycle in which replicated chromosomes are separated into two new nuclei. Such a division gives rise to genetically identical cells in which the total number of chromosomes is maintained [source:

Mitosis is a part of the cell cycle in which replicated chromosomes are separated into two new nuclei. Such a division gives rise to genetically identical cells in which the total number of chromosomes is maintained [source:

Massimo

505,583 Aufrufe • vor 3 Jahren

A single E. coli cell, placed on a dish, will become 70 billion cells in just 12 hours. That’s exponential growth. But a new preprint shows that it's possible to engineer E. coli to grow linearly instead, where only one daughter cell continues dividing and the other stops. First, some context. In nature, there is a bacterium called Mycobacterium smegmatis (initially discovered in 1884 in ulcers scraped from syphilis patients.) M. smegmatis is weird because it divides asymmetrically. These cells grow only from one end, and all their cell wall biosynthesis machinery is located on that one end. So when the cell divides, one daughter gets this machinery and the other gets nothing. The daughter that gets the machinery can keep dividing immediately, but the other daughter has to remake all that machinery from scratch, so its growth is delayed. E. coli doesn’t grow like this. When it divides, it pinches in the middle and splits everything evenly. Enzymes, metabolites, and proteins get partitioned more or less randomly between the two daughters. For the new preprint, though, researchers engineered E. coli to behave more like M. smegmatis. Here is how they did it: First, they deleted a gene called cyaA, which encodes an enzyme (adenylate cyclase) that makes a molecule called cAMP. cAMP is SUPER IMPORTANT! It is a nutrient sensor that instructs E. coli to switch on genes that help it digest non-glucose carbon sources when glucose is scarce. Without cAMP, E. coli cells growing on alternative carbon sources will starve; they won’t know how to eat the food. Next, they added back a “split” version of the cyaA gene into the cells. In other words, they split the gene in two so that each half of the enzyme is made separately. Cells can only make cAMP, and thus eat non-glucose carbon sources, if these two halves come together. To facilitate that “coming together,” the researchers also fused the split cyaA proteins to sticky proteins that clump together, and to a fluorescent protein (to make it easy to track these molecules in the cell.) So now some interesting things start to happen if you grow E. coli on a growth medium lacking glucose. As the cell grows, its cyaA “halves” start clumping together into a giant ball. Inside the aggregate, the two enzyme halves come together and make cAMP. And when the cell gets big enough and divides, the clump of cyaA RANDOMLY goes to either daughter cell #1 or #2. The daughter that gets the aggregate (called PA+ in this paper) can keep dividing. The daughter that doesn’t (PA–) cannot. It still grows a few times — about four divisions — because it inherits some leftover cAMP from its mother. But after that, the metabolite is diluted away, and the cell stops growing. PA+ cells went through about 23 divisions on average before their aggregate decayed. And the population of cells, as a whole, grew linearly. This paper is cool because there are many applications where exponential growth is too unpredictable and, perhaps, unsafe. If you want to engineer bacteria to deliver drugs, clean up waste, or live in the gut, you don’t want them to double uncontrollably. This paper shows you can make them expand in a controlled, linear way. Alas, mutations could break this whole engineered system. A mutation that restores cyaA, for example, would give cells a new way to make cAMP. Mutations that make the aggregates split between daughters would break the asymmetry, too. But still, I really enjoy proof-of-concept engineering papers like this.

A single E. coli cell, placed on a dish, will become 70 billion cells in just 12 hours. That’s exponential growth. But a new preprint shows that it's possible to engineer E. coli to grow linearly instead, where only one daughter cell continues dividing and the other stops. First, some context. In nature, there is a bacterium called Mycobacterium smegmatis (initially discovered in 1884 in ulcers scraped from syphilis patients.) M. smegmatis is weird because it divides asymmetrically. These cells grow only from one end, and all their cell wall biosynthesis machinery is located on that one end. So when the cell divides, one daughter gets this machinery and the other gets nothing. The daughter that gets the machinery can keep dividing immediately, but the other daughter has to remake all that machinery from scratch, so its growth is delayed. E. coli doesn’t grow like this. When it divides, it pinches in the middle and splits everything evenly. Enzymes, metabolites, and proteins get partitioned more or less randomly between the two daughters. For the new preprint, though, researchers engineered E. coli to behave more like M. smegmatis. Here is how they did it: First, they deleted a gene called cyaA, which encodes an enzyme (adenylate cyclase) that makes a molecule called cAMP. cAMP is SUPER IMPORTANT! It is a nutrient sensor that instructs E. coli to switch on genes that help it digest non-glucose carbon sources when glucose is scarce. Without cAMP, E. coli cells growing on alternative carbon sources will starve; they won’t know how to eat the food. Next, they added back a “split” version of the cyaA gene into the cells. In other words, they split the gene in two so that each half of the enzyme is made separately. Cells can only make cAMP, and thus eat non-glucose carbon sources, if these two halves come together. To facilitate that “coming together,” the researchers also fused the split cyaA proteins to sticky proteins that clump together, and to a fluorescent protein (to make it easy to track these molecules in the cell.) So now some interesting things start to happen if you grow E. coli on a growth medium lacking glucose. As the cell grows, its cyaA “halves” start clumping together into a giant ball. Inside the aggregate, the two enzyme halves come together and make cAMP. And when the cell gets big enough and divides, the clump of cyaA RANDOMLY goes to either daughter cell #1 or #2. The daughter that gets the aggregate (called PA+ in this paper) can keep dividing. The daughter that doesn’t (PA–) cannot. It still grows a few times — about four divisions — because it inherits some leftover cAMP from its mother. But after that, the metabolite is diluted away, and the cell stops growing. PA+ cells went through about 23 divisions on average before their aggregate decayed. And the population of cells, as a whole, grew linearly. This paper is cool because there are many applications where exponential growth is too unpredictable and, perhaps, unsafe. If you want to engineer bacteria to deliver drugs, clean up waste, or live in the gut, you don’t want them to double uncontrollably. This paper shows you can make them expand in a controlled, linear way. Alas, mutations could break this whole engineered system. A mutation that restores cyaA, for example, would give cells a new way to make cAMP. Mutations that make the aggregates split between daughters would break the asymmetry, too. But still, I really enjoy proof-of-concept engineering papers like this.

Niko McCarty.

58,028 Aufrufe • vor 11 Monaten

If you have Cancer, this is your visualization. That is a cancerous cell reaching Apoptosis and Necrosis—they are gone. — Natural Killer (NK) cells play a the primary role in the immune system's defense against cancer. They induce cancer cell death primarily through two mechanisms: Apoptosis Necrosis Apoptosis is a programmed, non-inflammatory form of cell death, while necrosis is a more abrupt and inflammatory process. In many cases, NK cells can trigger a combination of both, leading to mixed forms of cell death. This dual capability allows NK cells to effectively target and destroy all tumor cells. Their ability to act without prior sensitization makes them vital for early cancer surveillance and curing existing cancer. One of the only ways cancer never starts or stops entirely is NK cells. They are the guerrilla warfare troops that never sleep. This is why it is vital for BioShield by to be approved, NOW for every cancer, not just a single cancer type. With the rest needing years and years of tests. Cancer is cancer, unregulated cell division and NK cells are NK cells. The ONLY thing that stops BioShield is government betrayal, and organized corruption disguised as following the “regulations” designed by the entrenched gatekeepers of corporate protection. Everyone knows it works that has even a molecule of biological understanding. Now you know.

If you have Cancer, this is your visualization. That is a cancerous cell reaching Apoptosis and Necrosis—they are gone. — Natural Killer (NK) cells play a the primary role in the immune system's defense against cancer. They induce cancer cell death primarily through two mechanisms: Apoptosis Necrosis Apoptosis is a programmed, non-inflammatory form of cell death, while necrosis is a more abrupt and inflammatory process. In many cases, NK cells can trigger a combination of both, leading to mixed forms of cell death. This dual capability allows NK cells to effectively target and destroy all tumor cells. Their ability to act without prior sensitization makes them vital for early cancer surveillance and curing existing cancer. One of the only ways cancer never starts or stops entirely is NK cells. They are the guerrilla warfare troops that never sleep. This is why it is vital for BioShield by to be approved, NOW for every cancer, not just a single cancer type. With the rest needing years and years of tests. Cancer is cancer, unregulated cell division and NK cells are NK cells. The ONLY thing that stops BioShield is government betrayal, and organized corruption disguised as following the “regulations” designed by the entrenched gatekeepers of corporate protection. Everyone knows it works that has even a molecule of biological understanding. Now you know.

Brian Roemmele

191,436 Aufrufe • vor 8 Monaten

💪 Muscle cells merging in real time You’re watching one of [in my opinion] the coolest things your body does without you ever noticing (muscle precursor cells literally fusing into one long, powerful fiber). 🔵 Alignment: individual myoblasts migrate and line up like they’re preparing for formation 🟢 Recognition: cells “sense” compatible neighbors through surface proteins 🟡 Contact: membranes begin to thin and synchronize their signaling 🟠 Fusion: boundaries dissolve and nuclei gather inside a shared cytoplasm 🔴 Strengthening: the new multinucleated fiber becomes the machinery that lets you lift, run, and repair The glowing green nuclei are each a tiny command center contributed by a merging cell. The red signal traces the membranes as they stretch, touch, and finally blend into a unified structure. This is how muscles grow and regenerate - i.e. this is "strength" engineerednat the cellular level Credit: Yue Lu, Elizabeth Chen Lab

💪 Muscle cells merging in real time You’re watching one of [in my opinion] the coolest things your body does without you ever noticing (muscle precursor cells literally fusing into one long, powerful fiber). 🔵 Alignment: individual myoblasts migrate and line up like they’re preparing for formation 🟢 Recognition: cells “sense” compatible neighbors through surface proteins 🟡 Contact: membranes begin to thin and synchronize their signaling 🟠 Fusion: boundaries dissolve and nuclei gather inside a shared cytoplasm 🔴 Strengthening: the new multinucleated fiber becomes the machinery that lets you lift, run, and repair The glowing green nuclei are each a tiny command center contributed by a merging cell. The red signal traces the membranes as they stretch, touch, and finally blend into a unified structure. This is how muscles grow and regenerate - i.e. this is "strength" engineerednat the cellular level Credit: Yue Lu, Elizabeth Chen Lab

William A. Wallace, Ph.D.

40,387 Aufrufe • vor 7 Monaten

MR. POOL WHAT ACTUALLY HAPPENS INSIDE YOUR BODY WHEN YOU LIE ON A MEDBED MAT? You don't feel it happening. But at a microscopic level, a massive biological shift is taking place. When you lie down on the MedBed Home Therapy Mat, three specific frequencies penetrate your skin, bypass your bones, and enter your cells. Here is exactly what happens in the next 20 minutes: MINUTE 1-5: THE MITOCHONDRIA REBOOT The 660nm Red Light hits the mitochondria (the engine of your cells). If your cells are damaged or aging, they are struggling to produce energy. The red light forces them to instantly produce ATP (pure cellular energy). Your cells wake up. MINUTE 5-10: THE INFLAMMATION PURGE The 850nm Near-Infrared light goes deeper. It penetrates up to 8mm into your tissue, reaching muscles, joints, and organs. It triggers the release of nitric oxide, which dilates your blood vessels. Blood flow surges. Deep-tissue inflammation is flushed out. MINUTE 10-20: THE VOLTAGE SPIKE The PEMF (Pulsed Electromagnetic Field) activates. Healthy cells operate at 70mV. Sick, inflamed cells operate at 20mV. The PEMF recharges the electrical membrane of every cell in your body, spiking the voltage back to 70mV. At 70mV, your body stops surviving and starts regenerating. You don't swallow a pill. You don't inject a chemical. You just give your body the exact frequencies it needs to repair itself. Day 1: Sleep architecture deepens. Day 7: Joint stiffness and brain fog begin to clear. Day 14: Cellular regeneration is in full effect. Your body is a self-healing machine. It just lost its power source. Plug it back in. 📷📷📷 📷

MR. POOL WHAT ACTUALLY HAPPENS INSIDE YOUR BODY WHEN YOU LIE ON A MEDBED MAT? You don't feel it happening. But at a microscopic level, a massive biological shift is taking place. When you lie down on the MedBed Home Therapy Mat, three specific frequencies penetrate your skin, bypass your bones, and enter your cells. Here is exactly what happens in the next 20 minutes: MINUTE 1-5: THE MITOCHONDRIA REBOOT The 660nm Red Light hits the mitochondria (the engine of your cells). If your cells are damaged or aging, they are struggling to produce energy. The red light forces them to instantly produce ATP (pure cellular energy). Your cells wake up. MINUTE 5-10: THE INFLAMMATION PURGE The 850nm Near-Infrared light goes deeper. It penetrates up to 8mm into your tissue, reaching muscles, joints, and organs. It triggers the release of nitric oxide, which dilates your blood vessels. Blood flow surges. Deep-tissue inflammation is flushed out. MINUTE 10-20: THE VOLTAGE SPIKE The PEMF (Pulsed Electromagnetic Field) activates. Healthy cells operate at 70mV. Sick, inflamed cells operate at 20mV. The PEMF recharges the electrical membrane of every cell in your body, spiking the voltage back to 70mV. At 70mV, your body stops surviving and starts regenerating. You don't swallow a pill. You don't inject a chemical. You just give your body the exact frequencies it needs to repair itself. Day 1: Sleep architecture deepens. Day 7: Joint stiffness and brain fog begin to clear. Day 14: Cellular regeneration is in full effect. Your body is a self-healing machine. It just lost its power source. Plug it back in. 📷📷📷 📷

VAL THOR

22,785 Aufrufe • vor 2 Monaten

Some microbes carry a protein, called SNIPE, that "chops up" phage DNA as it's being injected into the cell. This is a new mechanism for phage defense! CRISPR–Cas and restriction enzymes also evolved to fight against phages, but they work by recognizing sequences. SNIPE works, instead, by sensing "touch." SNIPE is a protein with about 500 amino acids. After it's made by the ribosome, it latches onto ManYZ, two proteins which sit on the cell's inner membrane. (ManYZ is an importer; it brings mannose and other sugars into the cell.) Once attached to ManYZ, SNIPE sits and waits for an invading phage. Some phages, including lambda, actually infect cells by pushing their DNA through this ManYZ channel. Lambda uses its "tail" to reach inside the protein channel, basically, and inject its DNA. When this physical touch happens, though, SNIPE is waiting. As soon as the phage DNA starts entering the cell, and passes through ManYZ and SNIPE, it gets immediately destroyed. This means that SNIPE is the first phage defense system discovered, so far, that uses spatial positioning at the injection site to destroy invaders. But there are caveats, of course. If you untether SNIPE from ManYZ, such that it can freely diffuse through the cell, it will chew up the bacterium's genome. It is not a highly discerning nuclease! Also, SNIPE is not found in most bacteria. A prior pangenome study, which sequenced lots of different microbes, found that roughly a third of well-studied bacterial lineages had at least one member with a SNIPE-like protein. (For this paper, they just ported one of those homologs into an E. coli laboratory strain.) And finally, because SNIPE's mechanism is tightly tied to ManYZ, it cannot be used to defend against phages that enter the cell through different routes. T4 phages, for example, inject their DNA straight through the cell membrane and into the cytoplasm, without interacting with ManYZ. This is a nice basic science paper. Applications TBD. (Just remember that scientists figured out that bacteria had a phage defense system, called CRISPR-Cas, many years before it was repurposed into a gene-editing tool.) P.S. The video below shows how cells with the SNIPE gene (middle row) kill invading phages, and thus continue growing and dividing. Empty vector (top row) refers to bacteria carrying a plasmid with no SNIPE gene; this is a control group. And SNIPE E414A refers to cells which received a mutated SNIPE gene, where the glutamate at position 414 has been changed to an alanine, thus destroying the protein's nuclease activity. These cells also die when they get infected with a phage.

Some microbes carry a protein, called SNIPE, that "chops up" phage DNA as it's being injected into the cell. This is a new mechanism for phage defense! CRISPR–Cas and restriction enzymes also evolved to fight against phages, but they work by recognizing sequences. SNIPE works, instead, by sensing "touch." SNIPE is a protein with about 500 amino acids. After it's made by the ribosome, it latches onto ManYZ, two proteins which sit on the cell's inner membrane. (ManYZ is an importer; it brings mannose and other sugars into the cell.) Once attached to ManYZ, SNIPE sits and waits for an invading phage. Some phages, including lambda, actually infect cells by pushing their DNA through this ManYZ channel. Lambda uses its "tail" to reach inside the protein channel, basically, and inject its DNA. When this physical touch happens, though, SNIPE is waiting. As soon as the phage DNA starts entering the cell, and passes through ManYZ and SNIPE, it gets immediately destroyed. This means that SNIPE is the first phage defense system discovered, so far, that uses spatial positioning at the injection site to destroy invaders. But there are caveats, of course. If you untether SNIPE from ManYZ, such that it can freely diffuse through the cell, it will chew up the bacterium's genome. It is not a highly discerning nuclease! Also, SNIPE is not found in most bacteria. A prior pangenome study, which sequenced lots of different microbes, found that roughly a third of well-studied bacterial lineages had at least one member with a SNIPE-like protein. (For this paper, they just ported one of those homologs into an E. coli laboratory strain.) And finally, because SNIPE's mechanism is tightly tied to ManYZ, it cannot be used to defend against phages that enter the cell through different routes. T4 phages, for example, inject their DNA straight through the cell membrane and into the cytoplasm, without interacting with ManYZ. This is a nice basic science paper. Applications TBD. (Just remember that scientists figured out that bacteria had a phage defense system, called CRISPR-Cas, many years before it was repurposed into a gene-editing tool.) P.S. The video below shows how cells with the SNIPE gene (middle row) kill invading phages, and thus continue growing and dividing. Empty vector (top row) refers to bacteria carrying a plasmid with no SNIPE gene; this is a control group. And SNIPE E414A refers to cells which received a mutated SNIPE gene, where the glutamate at position 414 has been changed to an alanine, thus destroying the protein's nuclease activity. These cells also die when they get infected with a phage.

Niko McCarty.

20,516 Aufrufe • vor 5 Monaten

$🚨 Scientists discover wisdom teeth contain stem cells capable of repairing the heart, brain, and bones. Wisdom teeth contain dental pulp, a soft connective tissue threaded with blood vessels and nerves. Inside that pulp lives a dense population of mesenchymal stem cells, a class of undifferentiated cells that researchers classify as among the most therapeutically valuable biological material a human body produces. These are not ordinary cells maintaining routine tissue. They are blueprint cells, capable of receiving chemical signals from damaged environments and reshaping themselves into whatever the body needs most, neurons, cardiomyocytes, osteoblasts, even hepatic cells under the right conditions. The brain operates under a brutal rule: most of its neurons do not regenerate after damage. A stroke, a traumatic injury, a neurodegenerative disease removes cells the brain cannot replace through normal biological processes. Researchers have spent decades attempting to solve this through synthetic means, engineered cell therapies, growth factor injections, gene editing approaches that cost extraordinary resources and produce inconsistent results. What dental pulp stem cells demonstrated in laboratory conditions is that they can migrate toward neural damage sites, integrate with existing tissue architecture, and begin producing neurons and glial support cells. The mechanism involves neurotrophic factor secretion, essentially the cells releasing signaling proteins that stimulate the surrounding neural environment to repair itself from within. Cardiac muscle operates under a similarly unforgiving rule. After a heart attack, the dead muscle tissue becomes fibrotic scar material. The heart compensates by making surviving muscle work harder, a process that gradually leads to enlargement, weakening, and eventual failure. Dental pulp stem cells introduced into cardiac tissue in multiple studies produced measurable reductions in scar formation and demonstrated the ability to differentiate into functional cardiomyocytes, beating in synchrony with native heart cells. Some studies recorded improved ejection fraction in animal models, the core measurement of how effectively the heart pumps blood. Bone regeneration represents the most clinically advanced application already moving toward human trials. Dental pulp stem cells express high levels of osteogenic markers and respond rapidly to bone morphogenetic proteins, the chemical messengers that trigger skeletal repair. Their application in craniofacial reconstruction, spinal fusion, and long bone defect repair is being studied across multiple institutions simultaneously. What separates these cells from other stem cell sources is the combination of accessibility and biological youth. Bone marrow aspiration requires sedation and produces significant post procedure pain. Umbilical cord blood requires planning around birth. Wisdom teeth emerge between 17 and 25, during peak cellular vitality, and come out during a procedure most people already schedule. The extraction window is permanent. Once the teeth are gone and the pulp degrades, that specific population of young, highly potent cells is irretrievable from that individual. Cryogenic preservation protocols now exist that maintain dental pulp stem cell viability for over two decades. Several countries have commercial dental stem cell banks operating with the same institutional model as cord blood banking, long term frozen storage, indexed against future therapeutic need. The science supporting the value of preservation is no longer speculative. What lags behind is public awareness and clinical infrastructure in markets where this remains obscure. The wider pattern is worth recognizing. Medicine has repeatedly discovered that profound biological tools were present in tissues it previously categorized as vestigial, unnecessary, or inconvenient. The appendix was considered evolutionary junk for over a century before researchers identified its role in gut microbiome preservation. Wisdom teeth carried the same dismissal, a developmental relic from ancestors who needed extra molars for coarse diets, relevant only in their capacity to cause orthodontic problems. The pulp inside them was never junk. It was a repair system the body built during youth and stored in one of the most protected anatomical locations, surrounded by enamel, the hardest substance the human body produces. Evolution rarely wastes that kind of architecture.$

🚨 Scientists discover wisdom teeth contain stem cells capable of repairing the heart, brain, and bones. Wisdom teeth contain dental pulp, a soft connective tissue threaded with blood vessels and nerves. Inside that pulp lives a dense population of mesenchymal stem cells, a class of undifferentiated cells that researchers classify as among the most therapeutically valuable biological material a human body produces. These are not ordinary cells maintaining routine tissue. They are blueprint cells, capable of receiving chemical signals from damaged environments and reshaping themselves into whatever the body needs most, neurons, cardiomyocytes, osteoblasts, even hepatic cells under the right conditions. The brain operates under a brutal rule: most of its neurons do not regenerate after damage. A stroke, a traumatic injury, a neurodegenerative disease removes cells the brain cannot replace through normal biological processes. Researchers have spent decades attempting to solve this through synthetic means, engineered cell therapies, growth factor injections, gene editing approaches that cost extraordinary resources and produce inconsistent results. What dental pulp stem cells demonstrated in laboratory conditions is that they can migrate toward neural damage sites, integrate with existing tissue architecture, and begin producing neurons and glial support cells. The mechanism involves neurotrophic factor secretion, essentially the cells releasing signaling proteins that stimulate the surrounding neural environment to repair itself from within. Cardiac muscle operates under a similarly unforgiving rule. After a heart attack, the dead muscle tissue becomes fibrotic scar material. The heart compensates by making surviving muscle work harder, a process that gradually leads to enlargement, weakening, and eventual failure. Dental pulp stem cells introduced into cardiac tissue in multiple studies produced measurable reductions in scar formation and demonstrated the ability to differentiate into functional cardiomyocytes, beating in synchrony with native heart cells. Some studies recorded improved ejection fraction in animal models, the core measurement of how effectively the heart pumps blood. Bone regeneration represents the most clinically advanced application already moving toward human trials. Dental pulp stem cells express high levels of osteogenic markers and respond rapidly to bone morphogenetic proteins, the chemical messengers that trigger skeletal repair. Their application in craniofacial reconstruction, spinal fusion, and long bone defect repair is being studied across multiple institutions simultaneously. What separates these cells from other stem cell sources is the combination of accessibility and biological youth. Bone marrow aspiration requires sedation and produces significant post procedure pain. Umbilical cord blood requires planning around birth. Wisdom teeth emerge between 17 and 25, during peak cellular vitality, and come out during a procedure most people already schedule. The extraction window is permanent. Once the teeth are gone and the pulp degrades, that specific population of young, highly potent cells is irretrievable from that individual. Cryogenic preservation protocols now exist that maintain dental pulp stem cell viability for over two decades. Several countries have commercial dental stem cell banks operating with the same institutional model as cord blood banking, long term frozen storage, indexed against future therapeutic need. The science supporting the value of preservation is no longer speculative. What lags behind is public awareness and clinical infrastructure in markets where this remains obscure. The wider pattern is worth recognizing. Medicine has repeatedly discovered that profound biological tools were present in tissues it previously categorized as vestigial, unnecessary, or inconvenient. The appendix was considered evolutionary junk for over a century before researchers identified its role in gut microbiome preservation. Wisdom teeth carried the same dismissal, a developmental relic from ancestors who needed extra molars for coarse diets, relevant only in their capacity to cause orthodontic problems. The pulp inside them was never junk. It was a repair system the body built during youth and stored in one of the most protected anatomical locations, surrounded by enamel, the hardest substance the human body produces. Evolution rarely wastes that kind of architecture.

The Curious Tales

24,267 Aufrufe • vor 4 Monaten

🚨 SCIENTISTS MAY HAVE FOUND A WAY TO STOP BLINDNESS BEFORE VISION IS LOST. Researchers have developed a new laser-based treatment that gently heats the back of the eye not to destroy tissue, but to activate the eye’s own repair systems. The target is dry age-related macular degeneration (AMD) one of the leading causes of blindness worldwide. Around one in three people over 80 develop it, and until now there have been almost no ways to stop it early. Why this matters: Instead of waiting for vision loss and then trying to replace damaged cells, this treatment uses precisely controlled near-infrared laser pulses to raise retinal temperature by just a few degrees. That tiny heat signal triggers: • heat shock proteins • cellular repair mechanisms • autophagy (the cell’s own waste-removal process) In simple terms: the laser may help aging eye cells clean and repair themselves before permanent damage occurs. The deeper implication is enormous: Future medicine may not always work by replacing broken parts. It may work by reactivating the repair systems evolution already built into us. What if many age-related diseases, including blindness, begin when our cells simply lose the ability to clean up after themselves? Follow for more frontier medicine and future science.

🚨 SCIENTISTS MAY HAVE FOUND A WAY TO STOP BLINDNESS BEFORE VISION IS LOST. Researchers have developed a new laser-based treatment that gently heats the back of the eye not to destroy tissue, but to activate the eye’s own repair systems. The target is dry age-related macular degeneration (AMD) one of the leading causes of blindness worldwide. Around one in three people over 80 develop it, and until now there have been almost no ways to stop it early. Why this matters: Instead of waiting for vision loss and then trying to replace damaged cells, this treatment uses precisely controlled near-infrared laser pulses to raise retinal temperature by just a few degrees. That tiny heat signal triggers: • heat shock proteins • cellular repair mechanisms • autophagy (the cell’s own waste-removal process) In simple terms: the laser may help aging eye cells clean and repair themselves before permanent damage occurs. The deeper implication is enormous: Future medicine may not always work by replacing broken parts. It may work by reactivating the repair systems evolution already built into us. What if many age-related diseases, including blindness, begin when our cells simply lose the ability to clean up after themselves? Follow for more frontier medicine and future science.

TheNewPhysics

43,943 Aufrufe • vor 2 Monaten

🚨 BREAKING NEWS 🚨 Humans are now entering the first FDA-approved trial of partial epigenetic reprogramming. This is one of the biggest longevity experiments ever attempted. The idea comes from the Yamanaka factors: special genetic instructions that can reset a cell’s biological age. A full reset turns cells back into stem cells dangerous and potentially cancerous. But scientists discovered something remarkable: A partial reset may rejuvenate cells while preserving their identity. Not replacing the cell. Refreshing it. In mice, versions of this approach restored vision, repaired damaged tissue, and extended lifespan dramatically in some studies. Now the technology is moving into human trials targeting the eye. Why the eye? Because it’s isolated, measurable, and easier to monitor safely. The deeper implication is massive: Aging may not just be damage accumulation. It may partly be an information problem. Cells might carry a kind of biological “memory corruption” over time and epigenetic reprogramming could restore the original instructions. Not immortality. But potentially the first real step toward programmable aging. Follow me if you want to see where biology becomes code.

🚨 BREAKING NEWS 🚨 Humans are now entering the first FDA-approved trial of partial epigenetic reprogramming. This is one of the biggest longevity experiments ever attempted. The idea comes from the Yamanaka factors: special genetic instructions that can reset a cell’s biological age. A full reset turns cells back into stem cells dangerous and potentially cancerous. But scientists discovered something remarkable: A partial reset may rejuvenate cells while preserving their identity. Not replacing the cell. Refreshing it. In mice, versions of this approach restored vision, repaired damaged tissue, and extended lifespan dramatically in some studies. Now the technology is moving into human trials targeting the eye. Why the eye? Because it’s isolated, measurable, and easier to monitor safely. The deeper implication is massive: Aging may not just be damage accumulation. It may partly be an information problem. Cells might carry a kind of biological “memory corruption” over time and epigenetic reprogramming could restore the original instructions. Not immortality. But potentially the first real step toward programmable aging. Follow me if you want to see where biology becomes code.

TheNewPhysics

60,171 Aufrufe • vor 2 Monaten

Israel is building tiny robots inside your body. Researchers at the Technion have developed DNA origami nanorobots, programmable microscopic machines (just 100 nanometers wide) made entirely from DNA. These tiny “robots” navigate through the bloodstream, detect specific cancer cell markers, and then deploy a targeted toxin directly into tumors, while completely sparing healthy cells. In recent trials on aggressive cancers, they’ve shown incredible precision and effectiveness. This isn’t science fiction anymore. It’s Israeli innovation turning the body into its own battlefield against disease. From the lab bench to potentially saving millions of lives worldwide. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanorobotics #DNAOrigami #CancerTreatment

Israel is building tiny robots inside your body. Researchers at the Technion have developed DNA origami nanorobots, programmable microscopic machines (just 100 nanometers wide) made entirely from DNA. These tiny “robots” navigate through the bloodstream, detect specific cancer cell markers, and then deploy a targeted toxin directly into tumors, while completely sparing healthy cells. In recent trials on aggressive cancers, they’ve shown incredible precision and effectiveness. This isn’t science fiction anymore. It’s Israeli innovation turning the body into its own battlefield against disease. From the lab bench to potentially saving millions of lives worldwide. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanorobotics #DNAOrigami #CancerTreatment

Mor Edge Insight

1,105,572 Aufrufe • vor 2 Monaten

Inside every cell, there is a transport system that determines how materials move, signals propagate, and structure is maintained. This video captures that system in motion. The glowing streaks mark the growing ends of microtubules (protein polymers that constantly assemble and disassemble through a process called dynamic instability). Rather than forming permanent tracks, microtubules are rebuilt continuously, allowing cells to reorganize their internal layout in real time. This behavior is essential for life. Cells rely on microtubule dynamics to divide accurately, migrate during development and repair, and maintain long-distance transport in neurons that may span over a meter in length. When this system is altered, the consequences are significant. Certain cancer therapies work by locking microtubules in place, preventing cell division. In contrast, failures in microtubule transport are linked to neurodegenerative conditions (like Alzheimer's) where intracellular delivery breaks down. What appears as abstract motion under a microscope is actually one of the core systems that keeps cells functional, adaptable, and alive. Video Credit: Andy Moore

Inside every cell, there is a transport system that determines how materials move, signals propagate, and structure is maintained. This video captures that system in motion. The glowing streaks mark the growing ends of microtubules (protein polymers that constantly assemble and disassemble through a process called dynamic instability). Rather than forming permanent tracks, microtubules are rebuilt continuously, allowing cells to reorganize their internal layout in real time. This behavior is essential for life. Cells rely on microtubule dynamics to divide accurately, migrate during development and repair, and maintain long-distance transport in neurons that may span over a meter in length. When this system is altered, the consequences are significant. Certain cancer therapies work by locking microtubules in place, preventing cell division. In contrast, failures in microtubule transport are linked to neurodegenerative conditions (like Alzheimer's) where intracellular delivery breaks down. What appears as abstract motion under a microscope is actually one of the core systems that keeps cells functional, adaptable, and alive. Video Credit: Andy Moore

William A. Wallace, Ph.D.

18,469 Aufrufe • vor 5 Monaten

Your every thought, memory, and movement begins here: an electric spark turned chemical message, as one neuron whispers to the next. What you’re seeing This animation captures neurotransmission, the process that allows nerve cells to communicate across microscopic gaps called synapses. When an electrical impulse reaches the end of Cell A (the presynaptic neuron), it triggers the release of neurotransmitters—tiny signaling molecules that cross the synaptic cleft and bind to receptors on Cell B (the postsynaptic neuron). 🟡 Opens ion channels that generate a new electrical signal in the next neuron 🟡 Coordinates how the brain encodes movement, emotion, and thought 🟡 Operates on millisecond precision using hundreds of molecular components 💡 The bigger picture Neurotransmission is the foundation of consciousness, a seamless conversation of electricity and chemistry happening trillions of times each second. Every sensation, decision, and memory depends on this invisible dialogue between your brain’s 86 billion neurons.

Your every thought, memory, and movement begins here: an electric spark turned chemical message, as one neuron whispers to the next. What you’re seeing This animation captures neurotransmission, the process that allows nerve cells to communicate across microscopic gaps called synapses. When an electrical impulse reaches the end of Cell A (the presynaptic neuron), it triggers the release of neurotransmitters—tiny signaling molecules that cross the synaptic cleft and bind to receptors on Cell B (the postsynaptic neuron). 🟡 Opens ion channels that generate a new electrical signal in the next neuron 🟡 Coordinates how the brain encodes movement, emotion, and thought 🟡 Operates on millisecond precision using hundreds of molecular components 💡 The bigger picture Neurotransmission is the foundation of consciousness, a seamless conversation of electricity and chemistry happening trillions of times each second. Every sensation, decision, and memory depends on this invisible dialogue between your brain’s 86 billion neurons.

William A. Wallace, Ph.D.

125,496 Aufrufe • vor 8 Monaten

🚨 FOR THE FIRST TIME, SCIENTISTS RESTORED HEARING USING STEM CELLS Researchers injected lab-grown stem cells into damaged human ears… and some patients regained measurable hearing ability. The goal? Repair the tiny sensory hair cells and neurons inside the cochlea that normally never regenerate once destroyed. This is massive because hearing loss affects hundreds of millions of people worldwide… and most current treatments only compensate for damage rather than actually repairing it. Why this matters: • Could restore natural hearing instead of amplifying sound • May help reverse certain forms of deafness • Opens the door to regenerating damaged sensory tissue • Could eventually treat tinnitus and nerve-related hearing disorders • Pushes regenerative medicine into real human neural repair The deeper implication? We’re entering an era where medicine may stop managing damage… and start rebuilding biology itself. Your body may not be as permanent as we once thought. Follow for more future physics and breakthrough technology.

🚨 FOR THE FIRST TIME, SCIENTISTS RESTORED HEARING USING STEM CELLS Researchers injected lab-grown stem cells into damaged human ears… and some patients regained measurable hearing ability. The goal? Repair the tiny sensory hair cells and neurons inside the cochlea that normally never regenerate once destroyed. This is massive because hearing loss affects hundreds of millions of people worldwide… and most current treatments only compensate for damage rather than actually repairing it. Why this matters: • Could restore natural hearing instead of amplifying sound • May help reverse certain forms of deafness • Opens the door to regenerating damaged sensory tissue • Could eventually treat tinnitus and nerve-related hearing disorders • Pushes regenerative medicine into real human neural repair The deeper implication? We’re entering an era where medicine may stop managing damage… and start rebuilding biology itself. Your body may not be as permanent as we once thought. Follow for more future physics and breakthrough technology.

TheNewPhysics

48,859 Aufrufe • vor 2 Monaten

Today I received my 4th infusion of SGF (Stem Cell Growth Factors) at Edogawa Hospital in Tokyo, Japan. What is SGF? 🦷 SGF is derived from the dental pulp of children's naturally shed baby teeth. No stem cells are injected. Instead, the infusion contains the signaling molecules, growth factors, cytokines, and regenerative proteins that stem cells naturally produce. These biological messengers help coordinate communication between cells and are believed to support tissue repair, immune regulation, blood vessel health, and nerve regeneration. These growth factors are small enough to cross the blood brain barrier and reach the brain and nervous system directly. For someone like me with confirmed neuroinflammation, white matter atrophy, and small fiber neuropathy destroying my nerves from the inside out, the goal is remyelination. Rebuilding the insulation around my damaged nerve fibers.💯 Researchers have studied SHED (Stem Cells from Human Exfoliated Deciduous Teeth) for their regenerative potential in areas such as nerve repair, neuroinflammation, tissue healing, and age-related degeneration. Some people have nicknamed therapies like this the "Fountain of Youth" because the goal is not to replace damaged tissue, but to activate the body's own repair and regeneration pathways. Whether that nickname is deserved remains to be seen, but the science behind cellular signaling and regeneration is fascinating. Japan has become a global leader in regenerative medicine and allows access to therapies that are not currently available in the United States under its regenerative medicine framework. As Patient #27 in the McCairn–Edogawa Protocol, I am grateful to have the opportunity to experience this emerging science firsthand. 🧬🦷🇯🇵 #SGF #SHED #RegenerativeMedicine #StemCellScience #Neuroinflammation #SmallFiberNeuropathy #EdogawaHospital #Tokyo #MedicalInnovation

Today I received my 4th infusion of SGF (Stem Cell Growth Factors) at Edogawa Hospital in Tokyo, Japan. What is SGF? 🦷 SGF is derived from the dental pulp of children's naturally shed baby teeth. No stem cells are injected. Instead, the infusion contains the signaling molecules, growth factors, cytokines, and regenerative proteins that stem cells naturally produce. These biological messengers help coordinate communication between cells and are believed to support tissue repair, immune regulation, blood vessel health, and nerve regeneration. These growth factors are small enough to cross the blood brain barrier and reach the brain and nervous system directly. For someone like me with confirmed neuroinflammation, white matter atrophy, and small fiber neuropathy destroying my nerves from the inside out, the goal is remyelination. Rebuilding the insulation around my damaged nerve fibers.💯 Researchers have studied SHED (Stem Cells from Human Exfoliated Deciduous Teeth) for their regenerative potential in areas such as nerve repair, neuroinflammation, tissue healing, and age-related degeneration. Some people have nicknamed therapies like this the "Fountain of Youth" because the goal is not to replace damaged tissue, but to activate the body's own repair and regeneration pathways. Whether that nickname is deserved remains to be seen, but the science behind cellular signaling and regeneration is fascinating. Japan has become a global leader in regenerative medicine and allows access to therapies that are not currently available in the United States under its regenerative medicine framework. As Patient #27 in the McCairn–Edogawa Protocol, I am grateful to have the opportunity to experience this emerging science firsthand. 🧬🦷🇯🇵 #SGF #SHED #RegenerativeMedicine #StemCellScience #Neuroinflammation #SmallFiberNeuropathy #EdogawaHospital #Tokyo #MedicalInnovation

Heather C

28,961 Aufrufe • vor 1 Monat

Two-year-and-nine-month-old Hussein Al-Muqannan has been diagnosed with acute lymphoblastic leukemia (ALL) after his condition rapidly deteriorated, causing severe pain in his limbs, widespread bruising, and severe paleness due to the disease's impact on his bone marrow. Medical tests revealed a severe deficiency in all blood cell types, with his platelet count dropping to just 19,000, significantly increasing his risk of bleeding. He is also suffering from anemia, while cancerous cells account for 67% of the cells examined, confirming the severity of his condition. Doctors stress that Hussein urgently needs to begin treatment at a specialized pediatric oncology and hematology center. His immediate medical transfer abroad has become a critical necessity, as any delay could put his life at risk.

Two-year-and-nine-month-old Hussein Al-Muqannan has been diagnosed with acute lymphoblastic leukemia (ALL) after his condition rapidly deteriorated, causing severe pain in his limbs, widespread bruising, and severe paleness due to the disease's impact on his bone marrow. Medical tests revealed a severe deficiency in all blood cell types, with his platelet count dropping to just 19,000, significantly increasing his risk of bleeding. He is also suffering from anemia, while cancerous cells account for 67% of the cells examined, confirming the severity of his condition. Doctors stress that Hussein urgently needs to begin treatment at a specialized pediatric oncology and hematology center. His immediate medical transfer abroad has become a critical necessity, as any delay could put his life at risk.

TIMES OF GAZA

28,561 Aufrufe • vor 17 Tagen

this is ACTUALLY insane. shipping one teardown is the demo. this is what the workflow is actually for. your best ad dies in two weeks. you can't run it harder without burning it out, and you can't clone your way out because andromeda clusters the copies into one entity. nineteen never spend. your winner stays a one-shot, which is rough when it's the only thing working. the brands that scale keep the structure that converts and rebuild everything on top of it. same bones, new person, new setting. distinct enough that the algo reads each as its own ad. the production loop isn't there to ship your winner once. it's there to rebuild it twenty times before it burns.

this is ACTUALLY insane. shipping one teardown is the demo. this is what the workflow is actually for. your best ad dies in two weeks. you can't run it harder without burning it out, and you can't clone your way out because andromeda clusters the copies into one entity. nineteen never spend. your winner stays a one-shot, which is rough when it's the only thing working. the brands that scale keep the structure that converts and rebuild everything on top of it. same bones, new person, new setting. distinct enough that the algo reads each as its own ad. the production loop isn't there to ship your winner once. it's there to rebuild it twenty times before it burns.

Sulfur

11,066 Aufrufe • vor 1 Monat

The last video of Jeffrey Epstein alive: Trump officials release tape of paedophile financier walking to prison cell where he allegedly killed himself- The footage, released on the DoJ's website as part of the investigation that was started following a campaign pledge by US president Donald Trump, appears to show the orange-clad paedophile being led to his cells by a guard and being trailed by a second one at 7.49pm on the night of August 9. The two guards and Epstein were apparently seen walking across the common area as they move to his cell in the video, according to US news site Axios. The DoJ said that while the footage, which was taken between 7.40pm and 6.40am the next day, doesn't show his cell door, it would capture anyone moving to it. Read:

The last video of Jeffrey Epstein alive: Trump officials release tape of paedophile financier walking to prison cell where he allegedly killed himself- The footage, released on the DoJ's website as part of the investigation that was started following a campaign pledge by US president Donald Trump, appears to show the orange-clad paedophile being led to his cells by a guard and being trailed by a second one at 7.49pm on the night of August 9. The two guards and Epstein were apparently seen walking across the common area as they move to his cell in the video, according to US news site Axios. The DoJ said that while the footage, which was taken between 7.40pm and 6.40am the next day, doesn't show his cell door, it would capture anyone moving to it. Read:

Karli Bonne’ 🇺🇸

16,096 Aufrufe • vor 1 Jahr

Before Your Heart Ever Beat Once, Thousands of Cells Made a Silent Decision That Still Controls You Today. Before a heart ever beats, life organizes itself in complete silence. Scientists have captured the exact moment when cardiac cells begin acting as one second before the very first heartbeat exists. No heart chamber. No pumping. No pulse. Instead, thousands of individual cells synchronize their electrical signals, creating a wave of energy that triggers the heart's first contraction - and sets a rhythm that can last a lifetime. Using fluorescent proteins and ultra-high-resolution microscopy, researchers watched this electrical chain reaction spread, transforming biological chaos into perfect coordination. This is how the heart builds its own internal clock from—nothing. Why it matters: Disruptions at this stage can lead to congenital heart conditions This discovery is a major leap in developmental biology and medicine This is the origin story of every heartbeat you've ever had.

Before Your Heart Ever Beat Once, Thousands of Cells Made a Silent Decision That Still Controls You Today. Before a heart ever beats, life organizes itself in complete silence. Scientists have captured the exact moment when cardiac cells begin acting as one second before the very first heartbeat exists. No heart chamber. No pumping. No pulse. Instead, thousands of individual cells synchronize their electrical signals, creating a wave of energy that triggers the heart's first contraction - and sets a rhythm that can last a lifetime. Using fluorescent proteins and ultra-high-resolution microscopy, researchers watched this electrical chain reaction spread, transforming biological chaos into perfect coordination. This is how the heart builds its own internal clock from—nothing. Why it matters: Disruptions at this stage can lead to congenital heart conditions This discovery is a major leap in developmental biology and medicine This is the origin story of every heartbeat you've ever had.

Brian Roemmele

178,903 Aufrufe • vor 7 Monaten

AI is not accelerating nearly fast enough to cure cancer. That is the problem. And it literally cannot without actually seeing what’s happening inside the cell. There’s this new project claiming their models will “solve” cancer by predicting drug responses at scale. Cool story. Except their entire approach still treats the cell like a black box. They’re optimizing for binding affinity while having zero idea what the drug actually does once it’s inside a real, living cell. Meanwhile we’re over here building the tools to watch the cell in real time. No staining or sequencing. Just direct observation of mechanism. You can simulate all you want. But if you can’t see the actual cellular response, you’re just making very confident guesses about something you’ve never actually looked at. We’ve spent two years proving this. The data is there. The difference is night and day. AI is a tool. It’s not the microscope. If your model can’t tell you why a drug is killing the wrong cells or why resistance is forming in real time… it’s not ready to cure cancer. It’s ready to waste another billion dollars. We’re not competing with AI. We’re giving it eyes. Goodbye.

AI is not accelerating nearly fast enough to cure cancer. That is the problem. And it literally cannot without actually seeing what’s happening inside the cell. There’s this new project claiming their models will “solve” cancer by predicting drug responses at scale. Cool story. Except their entire approach still treats the cell like a black box. They’re optimizing for binding affinity while having zero idea what the drug actually does once it’s inside a real, living cell. Meanwhile we’re over here building the tools to watch the cell in real time. No staining or sequencing. Just direct observation of mechanism. You can simulate all you want. But if you can’t see the actual cellular response, you’re just making very confident guesses about something you’ve never actually looked at. We’ve spent two years proving this. The data is there. The difference is night and day. AI is a tool. It’s not the microscope. If your model can’t tell you why a drug is killing the wrong cells or why resistance is forming in real time… it’s not ready to cure cancer. It’s ready to waste another billion dollars. We’re not competing with AI. We’re giving it eyes. Goodbye.

Parmita Mishra

48,203 Aufrufe • vor 1 Monat

"I tried carnivore for two weeks and felt awful at the gym." Your body has been running on glucose every three hours for the last thirty years. You then asked it, with five days' notice, to learn a new fuel system. Of course you felt awful. What was actually happening in those two weeks: - Glycogen stores depleting before being replenished from fat and protein - Sodium dropping rapidly without enough replacement - The liver upregulating gluconeogenesis (this takes weeks) - Ketone production ramping up gradually - The whole hormonal cascade recalibrating The transition is uncomfortable. The transition takes 4-6 weeks for most lifters, longer for some. You quit at day twelve and concluded the diet doesn't work. The diet didn't fail. You quit before the adaptation completed. This is like attempting to learn French, giving up after two lessons, and concluding French is impossible to learn. The conclusion is not about the language. It's about the time you gave it. Six weeks. Then judge.

"I tried carnivore for two weeks and felt awful at the gym." Your body has been running on glucose every three hours for the last thirty years. You then asked it, with five days' notice, to learn a new fuel system. Of course you felt awful. What was actually happening in those two weeks: - Glycogen stores depleting before being replenished from fat and protein - Sodium dropping rapidly without enough replacement - The liver upregulating gluconeogenesis (this takes weeks) - Ketone production ramping up gradually - The whole hormonal cascade recalibrating The transition is uncomfortable. The transition takes 4-6 weeks for most lifters, longer for some. You quit at day twelve and concluded the diet doesn't work. The diet didn't fail. You quit before the adaptation completed. This is like attempting to learn French, giving up after two lessons, and concluding French is impossible to learn. The conclusion is not about the language. It's about the time you gave it. Six weeks. Then judge.

Sama Hoole

37,748 Aufrufe • vor 1 Monat